{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:42:55Z","timestamp":1786120975155,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Public Hospital Reform and High-Quality Development Demonstration Research Fund for Gastrointestinal Oncology of Peking University Cancer Hospital Inner Mongolia Hospital","award":["2023 sggz073-03"],"award-info":[{"award-number":["2023 sggz073-03"]}]},{"name":"Joint Research Fund for Public Hospitals of Inner Mongolia Academy of Medical Sciences","award":["2023 gllh0139"],"award-info":[{"award-number":["2023 gllh0139"]}]},{"DOI":"10.13039\/501100004763","name":"Inner Mongolia Natural Science Foundation","doi-asserted-by":"crossref","award":["2024 qn08075"],"award-info":[{"award-number":["2024 qn08075"]}],"id":[{"id":"10.13039\/501100004763","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Inner Mongolia Medical University 2022 Higher Education Teaching Reform Research Fund","award":["NYJXGG2022131"],"award-info":[{"award-number":["NYJXGG2022131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02495-z","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:07:35Z","timestamp":1786068455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent PIK3CA-E545K mutation promotes cervical cancer growth and invasion via AKT\/mTOR signaling"],"prefix":"10.1007","volume":"301","author":[{"given":"Congxiu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2495_CR53","doi-asserted-by":"publisher","first-page":"156114","DOI":"10.1016\/j.prp.2025.156114","volume":"272","author":"X Abuduhailili","year":"2025","unstructured":"Abuduhailili X, Feng Y, Lu R, Li Y, Wang S (2025) RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer. Pathol Res Pract 272:156114","journal-title":"Pathol Res Pract"},{"key":"2495_CR54","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","volume":"380","author":"F Andre","year":"2019","unstructured":"Andre F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS et al (2019) Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer. N Engl J Med 380:1929\u20131940","journal-title":"N Engl J Med"},{"key":"2495_CR34","doi-asserted-by":"publisher","first-page":"82424","DOI":"10.18632\/oncotarget.10955","volume":"7","author":"W Arjumand","year":"2016","unstructured":"Arjumand W, Merry CD, Wang C, Saba E, McIntyre JB, Fang S et al (2016) Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells. Oncotarget 7:82424\u201382439","journal-title":"Oncotarget"},{"key":"2495_CR58","doi-asserted-by":"publisher","first-page":"13264","DOI":"10.3390\/ijms252413264","volume":"25","author":"R Aslam","year":"2024","unstructured":"Aslam R, Richards CE, Fay J (2024) Synergistic effects of the combination of alpelisib (PI3K Inhibitor) and ribociclib (CDK4\/6 Inhibitor) in preclinical colorectal cancer models. Int J Mol Sci 25:13264","journal-title":"Int J Mol Sci"},{"key":"2495_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-023-01425-5","volume":"16","author":"K Butler","year":"2023","unstructured":"Butler K, Banday AR (2023) APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential. J Hematol Oncol 16:31","journal-title":"J Hematol Oncol"},{"key":"2495_CR22","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41418-025-01505-8","volume":"32","author":"Z Chen","year":"2025","unstructured":"Chen Z, Niu K, Li M, Deng Y, Zhang J, Wei D et al (2025) GCLC desuccinylation regulated by oxidative stress protects human cancer cells from ferroptosis. Cell Death Differ 32:1679","journal-title":"Cell Death Differ"},{"key":"2495_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41420-025-02327-w","volume":"11","author":"G Cong","year":"2025","unstructured":"Cong G, Zhu X, Chen XR, Chen H, Chong W (2025) Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer. Cell Death Discov 11:40","journal-title":"Cell Death Discov"},{"key":"2495_CR2","first-page":"235","volume":"51","author":"TG D\u2019Aug\u00e8","year":"2024","unstructured":"D\u2019Aug\u00e8 TG, Donato VD, Giannini A (2024) Strategic approaches in management of early-stage cervical cancer: a comprehensive editorial. CEOG 51:235","journal-title":"CEOG"},{"key":"2495_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/2326-6066.CIR-21-0146","volume":"10","author":"AV DiMarco","year":"2022","unstructured":"DiMarco AV, Qin X, McKinney BJ, Garcia NMG, Van Alsten SC, Mendes EA et al (2022) APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses. Cancer Immunol Res 10:70\u201386","journal-title":"Cancer Immunol Res"},{"key":"2495_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41589-024-01761-8","volume":"21","author":"A Dini","year":"2025","unstructured":"Dini A, Barker H, Piki E, Sharma S, Raivola J, Murumagi A et al (2025) A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discovery. Nat Chem Biol 21:432\u2013442","journal-title":"Nat Chem Biol"},{"key":"2495_CR35","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s11033-018-4438-7","volume":"45","author":"J Fu","year":"2018","unstructured":"Fu J, Cheng J, Liu X, Li J, Wei C, Zheng X et al (2018) Evaluation genotypes of cancer cell lines HCC1954 and SiHa by short tandem repeat (STR) analysis and DNA sequencing. Mol Biol Rep 45:2689\u20132695","journal-title":"Mol Biol Rep"},{"key":"2495_CR55","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","volume":"23","author":"P Furet","year":"2013","unstructured":"Furet P, Guagnano V, Fairhurst RA, Imbach-Weese P, Bruce I, Knapp M et al (2013) Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett 23:3741\u20133748","journal-title":"Bioorg Med Chem Lett"},{"key":"2495_CR59","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1158\/0008-5472.CAN-21-1208","volume":"81","author":"J G\u00f3mez Tejeda Za\u00f1udo","year":"2021","unstructured":"G\u00f3mez Tejeda Za\u00f1udo J, Mao P (2021) Cell Line-Specific Network Models of ER(+) Breast Cancer Identify Potential PI3K\u03b1 Inhibitor Resistance Mechanisms and Drug Combinations. Cancer Res 81:4603\u20134617","journal-title":"Cancer Res"},{"key":"2495_CR49","doi-asserted-by":"publisher","first-page":"107327482513364","DOI":"10.1177\/10732748251336415","volume":"32","author":"RU Hakim","year":"2025","unstructured":"Hakim RU, Amin T, Ul Islam SMB (2025) Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies. Cancer Control 32:10732748251336415","journal-title":"Cancer Control"},{"key":"2495_CR43","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.3802\/jgo.2024.35.e102","volume":"35","author":"H He","year":"2024","unstructured":"He H, He M, Zhou Q, Tang Y, Wang J, Li X et al (2024) Genetic analysis of cervical cancer with lymph node metastasis. J Gynecol Oncol 35:e102","journal-title":"J Gynecol Oncol"},{"key":"2495_CR52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41598-024-84254-x","volume":"15","author":"Y Jia","year":"2025","unstructured":"Jia Y, Yang N, Tang S, Deng L, Wang Y, Cai X (2025) RUNX1 promotes proliferation of cervical cancer through TGFB2-MAPK pathway. Sci Rep 15:497","journal-title":"Sci Rep"},{"key":"2495_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13045-018-0674-5","volume":"11","author":"W Jiang","year":"2018","unstructured":"Jiang W, He T, Liu S, Zheng Y, Xiang L, Pei X et al (2018) The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the \u03b2-catenin\/SIRT3 signaling pathway in cervical cancer. J Hematol Oncol 11:139","journal-title":"J Hematol Oncol"},{"key":"2495_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1535-7163.MCT-19-0309","volume":"19","author":"W Jiang","year":"2020","unstructured":"Jiang W, Wu Y, He T, Zhu H, Ke G, Xiang L et al (2020) Targeting of \u03b2-Catenin Reverses Radioresistance of Cervical Cancer with the PIK3CA-E545K Mutation. Mol Cancer Ther 19:337\u2013347","journal-title":"Mol Cancer Ther"},{"key":"2495_CR57","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4143\/crt.2024.1195","volume":"57","author":"KH Kim","year":"2025","unstructured":"Kim KH, Hwang S, Kim MK, Park KU, Yun T, Lee KW et al (2025) Differential efficacy of alpelisib by PIK3CA mutation site in head and neck squamous cell carcinoma: an analysis from the KCSG HN 15\u201316 TRIUMPH trial. Cancer Res Treat 57:968\u2013980","journal-title":"Cancer Res Treat"},{"key":"2495_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-025-07546-8","volume":"16","author":"A Klein-Goldberg","year":"2025","unstructured":"Klein-Goldberg A, Voloshin T, Zemer Tov E, Paz R, Somri-Gannam L, Volodin A et al (2025) Role of the PI3K\/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields). Cell Death Dis 16:210","journal-title":"Cell Death Dis"},{"key":"2495_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41556-024-01409-8","volume":"26","author":"AW Lambert","year":"2024","unstructured":"Lambert AW, Zhang Y, Weinberg RA (2024) Cell-intrinsic and microenvironmental determinants of metastatic colonization. Nat Cell Biol 26:687\u2013697","journal-title":"Nat Cell Biol"},{"key":"2495_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41420-025-02410-2","volume":"11","author":"Z Li","year":"2025","unstructured":"Li Z, Zhu T, Wu Y, Yu Y, Zang Y, Yu L et al (2025) Functions and mechanisms of non-histone post-translational modifications in cancer progression. Cell Death Discov 11:125","journal-title":"Cell Death Discov"},{"key":"2495_CR32","doi-asserted-by":"publisher","first-page":"666106","DOI":"10.3389\/fgene.2021.666106","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Lian X, Zhang X, Zhu Y, Zhang W, Wang J et al (2021) ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma. Front Genet 12:666106","journal-title":"Front Genet"},{"key":"2495_CR24","first-page":"197","volume":"22","author":"X Ma","year":"2025","unstructured":"Ma X, Cheng Z, Guo C (2025) Insights into the DNA damage response and tumor drug resistance. Cancer Biol Med 22:197\u2013204","journal-title":"Cancer Biol Med"},{"key":"2495_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13027-025-00647-1","volume":"20","author":"N Mabizela","year":"2025","unstructured":"Mabizela N, Soko N, Wu HT, Naidoo R, Dandara C (2025) A comparative analysis of somatic mutational profiles according to HIV status among women with cervical intraepithelial neoplasia 3 (CIN3): a focus on hotspots in TP53, PIK3CA, PTEN, and EGFR. Infect Agent Cancer 20:18","journal-title":"Infect Agent Cancer"},{"key":"2495_CR5","doi-asserted-by":"publisher","first-page":"e1006211","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride AA, Warburton A (2017) The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog 13:e1006211","journal-title":"PLoS Pathog"},{"key":"2495_CR56","doi-asserted-by":"publisher","first-page":"107726","DOI":"10.1016\/j.compbiolchem.2022.107726","volume":"99","author":"M Mente\u015f","year":"2022","unstructured":"Mente\u015f M, Karakuzulu BB, U\u00e7ar GB, Yand\u0131m C (2022) Comparative molecular dynamics analyses on PIK3CA hotspot mutations with PI3K\u03b1 specific inhibitors and ATP. Comput Biol Chem 99:107726","journal-title":"Comput Biol Chem"},{"key":"2495_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41698-025-00975-w","volume":"9","author":"A Milsap","year":"2025","unstructured":"Milsap A, Tsai J, Jafry B, Kim A, Ali Kazmi SM, Verma N (2025) Comprehensive analysis of PIK3CA mutations in advanced colorectal cancer using circulating tumor DNA profiling. NPJ Precis Oncol 9:220","journal-title":"NPJ Precis Oncol"},{"key":"2495_CR11","doi-asserted-by":"publisher","first-page":"10567","DOI":"10.1038\/s41598-021-90139-0","volume":"11","author":"N Murakami","year":"2021","unstructured":"Murakami N, Asami Y, Yoshida H, Takayanagi D, Hirose S, Kuno I et al (2021) Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy. Sci Rep 11:10567","journal-title":"Sci Rep"},{"key":"2495_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12985-025-02675-0","volume":"22","author":"E Naderzadeh","year":"2025","unstructured":"Naderzadeh E, Kargar M, Mokhtari MJ, Farhadi A (2025) Activating transcription factor 3 induces oxidative stress and genotoxicity, transcriptionally modulating metastasis-related gene expression in human papillomavirus-infected cervical cancer. Virol J 22:46","journal-title":"Virol J"},{"key":"2495_CR39","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1002\/cam4.70052","volume":"13","author":"K Nakamura","year":"2024","unstructured":"Nakamura K, Ishikawa M, Kawano R, Aimono E, Mizuno T, Nohara S et al (2024) Characterizing multi-PIK3CA mutations across cancer types: Toward precision oncology. Cancer Med 13:e70052","journal-title":"Cancer Med"},{"key":"2495_CR28","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3390\/cells12202474","volume":"12","author":"SS Nazari","year":"2023","unstructured":"Nazari SS, Doyle AD, Bleck CKE, Yamada KM (2023) Long prehensile protrusions can facilitate cancer cell invasion through the basement membrane. Cells 12:2474","journal-title":"Cells"},{"key":"2495_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12881","volume":"506","author":"AI Ojesina","year":"2014","unstructured":"Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ et al (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506:371\u2013375","journal-title":"Nature"},{"key":"2495_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS (2020) Human papillomavirus and cervical cancer. J Obstet Gynaecol 40:602\u2013608","journal-title":"J Obstet Gynaecol"},{"key":"2495_CR18","doi-asserted-by":"publisher","first-page":"RP97335","DOI":"10.7554\/eLife.97335","volume":"13","author":"Y Peng","year":"2025","unstructured":"Peng Y, Yang J, Ao J, Li Y, Shen J, He X et al (2025) Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma. Elife 13:RP97335","journal-title":"Elife"},{"key":"2495_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00018-012-1115-1","volume":"70","author":"WJ Polacheck","year":"2013","unstructured":"Polacheck WJ, Zervantonakis IK, Kamm RD (2013) Tumor cell migration in complex microenvironments. Cell Mol Life Sci 70:1335\u20131356","journal-title":"Cell Mol Life Sci"},{"key":"2495_CR51","doi-asserted-by":"publisher","first-page":"e19072","DOI":"10.7717\/peerj.19072","volume":"13","author":"H Qu","year":"2025","unstructured":"Qu H, Zhao J, Zuo X, He H, Wang X, Li H et al (2025) TGF-beta-mediated activation of fibroblasts in cervical cancer: implications for tumor microenvironment and prognosis. PeerJ 13:e19072","journal-title":"PeerJ"},{"key":"2495_CR6","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.3390\/cancers13205137","volume":"13","author":"D Ramachandran","year":"2021","unstructured":"Ramachandran D, Dork T (2021) Genomic risk factors for cervical cancer. Cancers (Basel) 13:5137","journal-title":"Cancers (Basel)"},{"key":"2495_CR42","first-page":"2278","volume":"18","author":"S Razia","year":"2019","unstructured":"Razia S, Nakayama K, Nakamura K, Ishibashi T, Ishikawa M, Minamoto T et al (2019) Clinicopathological and biological analysis of PIK3CA mutation and amplification in cervical carcinomas. Exp Ther Med 18:2278\u20132284","journal-title":"Exp Ther Med"},{"key":"2495_CR9","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological S, Barretos Cancer H et al (2017) Baylor College of M, Beckman Research Institute of City of H, Integrated genomic and molecular characterization of cervical cancer. Nature. 543:378\u2013384","DOI":"10.1038\/nature21386"},{"key":"2495_CR30","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1080\/15384101.2024.2302243","volume":"22","author":"O Saatci","year":"2023","unstructured":"Saatci O, Sahin O (2023) TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness. Cell Cycle 22:2637\u20132655","journal-title":"Cell Cycle"},{"key":"2495_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41467-025-56150-z","volume":"16","author":"N Sasa","year":"2025","unstructured":"Sasa N, Kishikawa T, Mori M, Ito R, Mizoro Y, Suzuki M et al (2025) Intratumor heterogeneity of HPV integration in HPV-associated head and neck cancer. Nat Commun 16:1052","journal-title":"Nat Commun"},{"key":"2495_CR40","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1038\/s41598-024-62664-1","volume":"14","author":"C Schagerholm","year":"2024","unstructured":"Schagerholm C, Robertson S, Toosi H, Sifakis EG, Hartman J (2024) PIK3CA mutations in endocrine-resistant breast cancer. Sci Rep 14:12542","journal-title":"Sci Rep"},{"key":"2495_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2867-5-34","volume":"5","author":"H Sharma","year":"2005","unstructured":"Sharma H, Singh A, Sharma C, Jain SK, Singh N (2005) Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer. Cancer Cell Int 5:34","journal-title":"Cancer Cell Int"},{"key":"2495_CR1","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B et al (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 11:e197\u2013e206","journal-title":"Lancet Glob Health"},{"key":"2495_CR16","doi-asserted-by":"publisher","first-page":"12742","DOI":"10.1038\/s41598-023-39608-2","volume":"13","author":"M Sinkala","year":"2023","unstructured":"Sinkala M (2023) Mutational landscape of cancer-driver genes across human cancers. Sci Rep 13:12742","journal-title":"Sci Rep"},{"key":"2495_CR31","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.2147\/IJGM.S381188","volume":"15","author":"R Song","year":"2022","unstructured":"Song R, Huang J, Yang C, Li Y, Zhan G, Xiang B (2022) ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis. Int J Gen Med 15:8381\u20138398","journal-title":"Int J Gen Med"},{"key":"2495_CR45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan AC (2020) Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac Cancer 11:511\u2013518","journal-title":"Thorac Cancer"},{"key":"2495_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41573-021-00209-1","volume":"20","author":"B Vanhaesebroeck","year":"2021","unstructured":"Vanhaesebroeck B, Perry MWD, Brown JR, Andre F, Okkenhaug K (2021) PI3K inhibitors are finally coming of age. Nat Rev Drug Discov 20:741\u2013769","journal-title":"Nat Rev Drug Discov"},{"key":"2495_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13073-025-01445-5","volume":"17","author":"DJ Vis","year":"2025","unstructured":"Vis DJ, Palit SAL, Corradi M, Cuppen E, Mehra N, Lolkema MP et al (2025) Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications. Genome Med 17:24","journal-title":"Genome Med"},{"key":"2495_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/jcm10020220","volume":"10","author":"IA Voutsadakis","year":"2021","unstructured":"Voutsadakis IA (2021) PI3KCA mutations in uterine cervix carcinoma. J Clin Med 10:220","journal-title":"J Clin Med"},{"key":"2495_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12032-022-01942-2","volume":"40","author":"C Wang","year":"2023","unstructured":"Wang C, Bai R, Liu Y, Wang K, Wang Y, Yang J et al (2023) Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer. Med Oncol 40:78","journal-title":"Med Oncol"},{"key":"2495_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41565-023-01498-w","volume":"19","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liang Q, Dou J, Zhou H, Zeng C, Pan H et al (2024) Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours. Nat Nanotechnol 19:95\u2013105","journal-title":"Nat Nanotechnol"},{"key":"2495_CR8","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1002\/cncr.28288","volume":"119","author":"AA Wright","year":"2013","unstructured":"Wright AA, Howitt BE, Myers AP, Dahlberg SE, Palescandolo E, Van Hummelen P et al (2013) Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix. Cancer 119:3776\u20133783","journal-title":"Cancer"},{"key":"2495_CR47","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/cancers13071538","volume":"13","author":"SCE Wright","year":"2021","unstructured":"Wright SCE, Vasilevski N, Serra V, Rodon J, Eichhorn PJA (2021) Mechanisms of resistance to PI3K inhibitors in cancer: adaptive responses, drug tolerance and cellular plasticity. Cancers (Basel) 13:1538","journal-title":"Cancers (Basel)"},{"key":"2495_CR26","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.tranon.2020.100899","volume":"14","author":"JS Wu","year":"2021","unstructured":"Wu JS, Jiang J, Chen BJ, Wang K, Tang YL, Liang XH (2021) Plasticity of cancer cell invasion: Patterns and mechanisms. Transl Oncol 14:100899","journal-title":"Transl Oncol"},{"key":"2495_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cac2.12629","volume":"45","author":"M Xu","year":"2025","unstructured":"Xu M, Cao C, Wu P, Huang X, Ma D (2025) Advances in cervical cancer: current insights and future directions. Cancer Commun (Lond) 45:77\u2013109","journal-title":"Cancer Commun (Lond)"},{"key":"2495_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12885-025-13486-5","volume":"25","author":"M Yan","year":"2025","unstructured":"Yan M, Zong Z, Guo W, Li X, Li J, Xia X et al (2025) PIK3CA gene mutation status associated with poor prognosis of breast cancer: a retrospective cohort study. BMC Cancer 25:365","journal-title":"BMC Cancer"},{"key":"2495_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25259\/Cytojournal_178_2024","volume":"22","author":"X Yang","year":"2025","unstructured":"Yang X, Miao G, Wang Q, Yu Q, Hu Q, Tan G (2025) E2F1-mediated ESPL1 transcriptional activation predicts poor prognosis and promotes the proliferation of leiomyosarcoma. Cytojournal 22:3","journal-title":"Cytojournal"},{"key":"2495_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00204-023-03440-4","volume":"97","author":"M Yu","year":"2023","unstructured":"Yu M, Chen J, Xu Z, Yang B, He Q, Luo P et al (2023) Development and safety of PI3K inhibitors in cancer. Arch Toxicol 97:635\u2013650","journal-title":"Arch Toxicol"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02495-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T02:07:38Z","timestamp":1786068458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2495"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02495-z","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Human and Animal Ethics Committee of the The Affiliated Hospital of Inner Mongolia Medical University.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors did not use any AI-assisted technology.","order":4,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"165"}}